{
    "Trade/Device Name(s)": [
        "One Step HCG Urine Pregnancy Test",
        "One Step HCG Serum/Urine Combo Pregnancy Test"
    ],
    "Submitter Information": "AI DE Diagnostic, Co., Ltd.",
    "510(k) Number": "K062703",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI",
        "LCX"
    ],
    "Summary Letter Date": "July 23, 2007",
    "Summary Letter Received Date": "June 11, 2007",
    "Submission Date": "June 7, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Two-site sandwich immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for One Step HCG Pregnancy Tests (Urine and Serum/Urine Combo) using immunoassay for qualitative detection of hCG.",
    "Indications for Use Summary": "For qualitative determination of hCG in human urine (all formats) and serum (combo format) to aid early pregnancy detection; midstream format OTC, other formats OTC and professional use.",
    "fda_folder": "Clinical Chemistry"
}